• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子-α拮抗剂致急性肝衰竭:4 例报告并文献复习。

Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review.

机构信息

Division of Gastroenterology (Liver Unit), Department of Critical Care Medicine, University of Alberta, 1-40 Zeidler-Ledcor Building, Edmonton, AB, T6G-2X8, Canada.

Department of Surgery, University of Alberta, Edmonton, Canada.

出版信息

Dig Dis Sci. 2018 Jun;63(6):1654-1666. doi: 10.1007/s10620-018-5023-6. Epub 2018 Mar 21.

DOI:10.1007/s10620-018-5023-6
PMID:29564668
Abstract

BACKGROUND

Tumor necrosis factor-α antagonists (anti-TNF-α) have been associated with drug-induced liver injury. However, cases of anti-TNF-α-associated acute liver failure have only been rarely reported.

AIMS

To identify cases of anti-TNF-α-associated acute liver failure and evaluate patterns of liver injury and common characteristics to the cases.

METHODS

The United States Acute Liver Failure Study Group database was searched from 1998 to 2014. Four subjects were identified. A PubMed search for articles that reported anti-TNF-α-associated acute liver failure identified five additional cases.

RESULTS

The majority of individuals affected were female (eight of nine cases). Age of individual ranged from 20 to 53 years. The most common anti-TNF-α agent associated with acute liver failure was infliximab (n = 8). The latency between initial drug exposure and acute liver failure ranged from 3 days to over a year. Of the nine cases, six required emergency LT. Liver biopsy was obtained in seven cases with a preponderance toward cholestatic-hepatitic features; none showed clear autoimmune features.

CONCLUSIONS

Anti-TNF-α-associated acute liver failure displays somewhat different characteristics compared with anti-TNF-α-induced drug-induced liver injury. Infliximab was implicated in the majority of cases. Cholestatic-hepatitic features were frequently found on pre-transplant and explant histology.

摘要

背景

肿瘤坏死因子-α 拮抗剂(抗 TNF-α)与药物性肝损伤有关。然而,抗 TNF-α 相关性急性肝衰竭的病例却很少有报道。

目的

确定抗 TNF-α 相关性急性肝衰竭的病例,并评估肝损伤的模式和这些病例的共同特征。

方法

从 1998 年到 2014 年,检索美国急性肝衰竭研究组数据库。确定了 4 例病例。通过 PubMed 检索报告抗 TNF-α 相关性急性肝衰竭的文章,又确定了另外 5 例病例。

结果

大多数受影响的个体为女性(9 例中的 8 例)。个体年龄从 20 岁到 53 岁不等。与急性肝衰竭最相关的抗 TNF-α 药物是英夫利昔单抗(n = 8)。初次药物暴露与急性肝衰竭之间的潜伏期从 3 天到 1 年以上不等。在 9 例病例中,有 6 例需要紧急进行肝移植。7 例病例进行了肝活检,主要表现为胆汁淤积性肝炎特征;均无明确的自身免疫特征。

结论

与抗 TNF-α 诱导的药物性肝损伤相比,抗 TNF-α 相关性急性肝衰竭具有一些不同的特征。英夫利昔单抗与大多数病例有关。在移植前和肝移植组织学中经常发现胆汁淤积性肝炎特征。

相似文献

1
Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review.肿瘤坏死因子-α拮抗剂致急性肝衰竭:4 例报告并文献复习。
Dig Dis Sci. 2018 Jun;63(6):1654-1666. doi: 10.1007/s10620-018-5023-6. Epub 2018 Mar 21.
2
A case report: ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis.病例报告:溃疡性结肠炎,肿瘤坏死因子(英夫利昔单抗)抗体治疗,随后发生肝坏死。
J Crohns Colitis. 2012 Jul;6(6):724-7. doi: 10.1016/j.crohns.2012.02.004. Epub 2012 Mar 2.
3
Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.肿瘤坏死因子-α拮抗剂致肝损伤:34 例分析。
Clin Gastroenterol Hepatol. 2013 May;11(5):558-564.e3. doi: 10.1016/j.cgh.2012.12.025. Epub 2013 Jan 17.
4
[A 20-year-old woman with ulcerative colitis and acute liver failure].一名患有溃疡性结肠炎和急性肝衰竭的20岁女性
Internist (Berl). 2017 Sep;58(9):982-989. doi: 10.1007/s00108-017-0205-4.
5
New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.儿童抗肿瘤坏死因子-α治疗期间新发自身免疫性肝炎。
J Pediatr. 2018 Mar;194:128-135.e1. doi: 10.1016/j.jpeds.2017.10.071. Epub 2017 Dec 21.
6
Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report.英夫利昔单抗相关的溃疡性结肠炎暴发性肝衰竭:一例报告
J Med Case Rep. 2015 Oct 30;9:249. doi: 10.1186/s13256-015-0730-5.
7
Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.抗肿瘤坏死因子药物与肝损伤:文献综述及管理建议
World J Gastroenterol. 2014 Dec 14;20(46):17352-9. doi: 10.3748/wjg.v20.i46.17352.
8
Risk of drug-induced liver injury from tumor necrosis factor antagonists.肿瘤坏死因子拮抗剂致药物性肝损伤的风险。
Clin Gastroenterol Hepatol. 2015 Mar;13(3):602-8. doi: 10.1016/j.cgh.2014.07.062. Epub 2014 Aug 15.
9
Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.抗肿瘤坏死因子α在溃疡性结肠炎门诊治疗中的实际疗效
World J Gastroenterol. 2015 Mar 21;21(11):3282-90. doi: 10.3748/wjg.v21.i11.3282.
10
Nephrotic syndrome after infliximab treatment in a patient with ulcerative colitis.一名溃疡性结肠炎患者接受英夫利昔单抗治疗后出现肾病综合征。
J Gastrointestin Liver Dis. 2015 Jun;24(2):249-51. doi: 10.15403/jgld.2014.1121.242.infx.

引用本文的文献

1
Hepatotoxicity Associated with Adalimumab in Hidradenitis Suppurativa: A Report of Two Cases of Drug-Induced Liver Injury.阿达木单抗治疗化脓性汗腺炎相关肝毒性:两例药物性肝损伤报告
Dermatol Pract Concept. 2025 Jul 31;15(3):5320. doi: 10.5826/dpc.1503a5320.
2
Hepatotoxicity in inflammatory bowel disease: Immunomodulators, biologics, and beyond.炎症性肠病中的肝毒性:免疫调节剂、生物制剂及其他。
Clin Liver Dis (Hoboken). 2024 Jun 14;23(1):e0199. doi: 10.1097/CLD.0000000000000199. eCollection 2024 Jan-Jun.
3
[Risk factors of early myocardial injury and the impact of early myocardial injury on prognosis of patients with extensive burns].

本文引用的文献

1
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study.炎症性肠病中的药物性肝损伤:1年前瞻性观察研究。
World J Gastroenterol. 2017 Jun 14;23(22):4102-4111. doi: 10.3748/wjg.v23.i22.4102.
2
[A 20-year-old woman with ulcerative colitis and acute liver failure].一名患有溃疡性结肠炎和急性肝衰竭的20岁女性
Internist (Berl). 2017 Sep;58(9):982-989. doi: 10.1007/s00108-017-0205-4.
3
Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab.
[早期心肌损伤的危险因素及早期心肌损伤对大面积烧伤患者预后的影响]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 May 20;39(5):417-423. doi: 10.3760/cma.j.cn501225-20230308-00074.
4
The immunological mechanisms and therapeutic potential in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.药物性肝损伤的免疫机制及治疗潜力:对乙酰氨基酚肝毒性的经验教训
Cell Biosci. 2022 Nov 22;12(1):187. doi: 10.1186/s13578-022-00921-4.
5
Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury the TLR4/NF-κB Pathway.肝实质细胞条件性敲除磷脂酰乙醇胺结合蛋白 4 加剧 LPS/D-GalN 诱导的急性肝损伤:TLR4/NF-κB 通路。
Front Immunol. 2022 Jul 8;13:901566. doi: 10.3389/fimmu.2022.901566. eCollection 2022.
6
Infliximab-Induced Vanishing Bile Duct Syndrome.英夫利昔单抗诱导的小胆管消失综合征
Cureus. 2022 Feb 5;14(2):e21940. doi: 10.7759/cureus.21940. eCollection 2022 Feb.
7
Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.斯蒂尔病妊娠复发致急性肝衰竭:1 例报告并探讨药物性肝损伤(DILI)可能的触发作用。
BMC Gastroenterol. 2021 Aug 6;21(1):317. doi: 10.1186/s12876-021-01878-3.
8
Efficacy of artificial liver support system in severe immune-associated hepatitis caused by camrelizumab: A case report and review of the literature.人工肝支持系统在卡瑞利珠单抗所致严重免疫相关性肝炎中的疗效:一例病例报告及文献复习
World J Clin Cases. 2021 Jun 16;9(17):4415-4422. doi: 10.12998/wjcc.v9.i17.4415.
9
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes.探究免疫相关不良事件、糖皮质激素使用及免疫治疗中断对长期生存结局的影响。
Cancers (Basel). 2021 May 14;13(10):2365. doi: 10.3390/cancers13102365.
10
Infliximab-Induced Acute Liver Failure in a Patient With Crohn's Disease Requiring Orthotopic Liver Transplantation.英夫利昔单抗诱导的克罗恩病患者急性肝衰竭,需进行原位肝移植
ACG Case Rep J. 2021 May 14;8(5):e00586. doi: 10.14309/crj.0000000000000586. eCollection 2021 May.
接受阿达木单抗、依那西普和乌司奴单抗长期治疗的银屑病患者的常规实验室参数动态变化及实验室不良事件
Acta Derm Venereol. 2017 Jun 9;97(6):705-710. doi: 10.2340/00015555-2644.
4
A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study.在结核病和慢性肝病高流行率国家中生物治疗(阿达木单抗和依那西普)的真实世界风险分析:一项基于全国人群的研究
Scand J Rheumatol. 2017 May;46(3):236-240. doi: 10.1080/03009742.2016.1202318. Epub 2016 Oct 21.
5
Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab.炎症性肠病中肝酶升高:英夫利昔单抗的作用及安全性
Eur J Gastroenterol Hepatol. 2016 Jul;28(7):786-91. doi: 10.1097/MEG.0000000000000624.
6
Hepatotoxicity Associated with the Use of Anti-TNF-α Agents.与使用抗TNF-α药物相关的肝毒性。
Drug Saf. 2016 Mar;39(3):199-208. doi: 10.1007/s40264-015-0366-9.
7
Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report.英夫利昔单抗相关的溃疡性结肠炎暴发性肝衰竭:一例报告
J Med Case Rep. 2015 Oct 30;9:249. doi: 10.1186/s13256-015-0730-5.
8
Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States.美国等待肝移植的急性肝衰竭患者的预后决定因素。
Liver Transpl. 2016 Apr;22(4):505-15. doi: 10.1002/lt.24347.
9
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.自身免疫性肝炎与抗肿瘤坏死因子α治疗:单中心8例报告
World J Gastroenterol. 2015 Jun 28;21(24):7584-8. doi: 10.3748/wjg.v21.i24.7584.
10
New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease.炎症性肠病生物治疗中出现的新发特发性肝酶升高
Aliment Pharmacol Ther. 2015 May;41(10):972-9. doi: 10.1111/apt.13159. Epub 2015 Mar 10.